Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of IOL CHEMICALS & PHARM.. For more details, see the IOL CHEMICALS & PHARM. quarterly results and IOL CHEMICALS & PHARM. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.7 |
No. of shares | m | 58.71 |
1 Week | % | 3.6 |
1 Month | % | 3.0 |
1 Year | % | 0.4 |
52 week H/L | Rs | 535.6/350.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
IOL CHEMICALS & PHARM. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 225 | 317 | 898 | 725 | 537 | |
Low | Rs | 78 | 147 | 175 | 295 | 272 | |
Sales per share (Unadj.) | Rs | 296.2 | 333.0 | 335.0 | 372.0 | 377.6 | |
Earnings per share (Unadj.) | Rs | 41.6 | 63.5 | 75.7 | 28.6 | 23.7 | |
Diluted earnings per share | Rs | 40.3 | 61.5 | 75.7 | 28.6 | 23.7 | |
Cash flow per share (Unadj.) | Rs | 47.3 | 69.8 | 82.4 | 35.9 | 31.6 | |
Dividends per share (Unadj.) | Rs | 0 | 3.00 | 6.00 | 4.00 | 4.00 | |
Adj. dividends per share | Rs | 0.00 | 2.91 | 6.00 | 4.00 | 4.00 | |
Avg Dividend yield | % | 0 | 1.3 | 1.1 | 0.8 | 1.0 | |
Book value per share (Unadj.) | Rs | 81.7 | 141.4 | 214.7 | 237.1 | 256.8 | |
Adj. book value per share | Rs | 79.2 | 137.0 | 214.7 | 237.2 | 256.8 | |
Shares outstanding (eoy) | m | 56.89 | 56.89 | 58.71 | 58.71 | 58.71 | |
Price / Sales ratio | x | 0.5 | 0.7 | 1.6 | 1.4 | 1.1 | |
Avg P/E ratio | x | 3.6 | 3.7 | 7.1 | 17.9 | 17.1 | |
P/CF ratio (eoy) | x | 3.2 | 3.3 | 6.5 | 14.2 | 12.8 | |
Price / Book Value ratio | x | 1.9 | 1.6 | 2.5 | 2.2 | 1.6 | |
Dividend payout | % | 0 | 4.7 | 7.9 | 14.0 | 16.9 | |
Avg Mkt Cap | Rs m | 8,636 | 13,202 | 31,493 | 29,943 | 23,743 | |
Total wages/salary | Rs m | 784 | 972 | 1,156 | 1,413 | 1,682 |
IOL CHEMICALS & PHARM. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 16,853 | 18,945 | 19,670 | 21,840 | 22,171 | |
Other income | Rs m | 104 | 160 | 243 | 320 | 256 | |
Total revenues | Rs m | 16,957 | 19,105 | 19,913 | 22,161 | 22,427 | |
Gross profit | Rs m | 4,097 | 5,739 | 5,918 | 2,444 | 2,257 | |
Depreciation | Rs m | 325 | 357 | 389 | 433 | 462 | |
Interest | Rs m | 514 | 209 | 58 | 83 | 165 | |
Profit before tax | Rs m | 3,362 | 5,332 | 5,714 | 2,249 | 1,887 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 995 | 1,720 | 1,268 | 572 | 495 | |
Profit after tax | Rs m | 2,367 | 3,613 | 4,446 | 1,677 | 1,391 | |
Gross profit margin | % | 24.3 | 30.3 | 30.1 | 11.2 | 10.2 | |
Effective tax rate | % | 29.6 | 32.2 | 22.2 | 25.4 | 26.2 | |
Net profit margin | % | 14.0 | 19.1 | 22.6 | 7.7 | 6.3 |
IOL CHEMICALS & PHARM. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,522 | 8,479 | 11,522 | 11,427 | 9,667 | |
Current liabilities | Rs m | 3,248 | 4,536 | 4,328 | 5,753 | 5,025 | |
Net working cap to sales | % | 13.5 | 20.8 | 36.6 | 26.0 | 20.9 | |
Current ratio | x | 1.7 | 1.9 | 2.7 | 2.0 | 1.9 | |
Inventory Days | Days | 4 | 2 | 8 | 36 | 43 | |
Debtors Days | Days | 4 | 5 | 6 | 8 | 8 | |
Net fixed assets | Rs m | 4,576 | 4,990 | 6,002 | 8,815 | 11,017 | |
Share capital | Rs m | 569 | 569 | 587 | 587 | 587 | |
"Free" reserves | Rs m | 4,081 | 7,473 | 12,017 | 13,336 | 14,490 | |
Net worth | Rs m | 4,650 | 8,042 | 12,604 | 13,923 | 15,077 | |
Long term debt | Rs m | 1,899 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 10,098 | 13,469 | 17,523 | 20,242 | 20,684 | |
Interest coverage | x | 7.5 | 26.5 | 99.0 | 28.1 | 12.5 | |
Debt to equity ratio | x | 0.4 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 1.7 | 1.4 | 1.1 | 1.1 | 1.1 | |
Return on assets | % | 28.5 | 28.4 | 25.7 | 8.7 | 7.5 | |
Return on equity | % | 50.9 | 44.9 | 35.3 | 12.0 | 9.2 | |
Return on capital | % | 59.2 | 68.9 | 45.8 | 16.7 | 13.6 | |
Exports to sales | % | 34.9 | 31.1 | 26.8 | 22.2 | 26.7 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 5,884 | 5,895 | 5,272 | 4,838 | 5,930 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 5,884 | 5,895 | 5,272 | 4,838 | 5,930 | |
Fx outflow | Rs m | 2,934 | 4,035 | 5,004 | 8,238 | 6,052 | |
Net fx | Rs m | 2,950 | 1,860 | 268 | -3,400 | -122 |
IOL CHEMICALS & PHARM. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,732 | 4,708 | 3,798 | 931 | 1,223 | |
From Investments | Rs m | -630 | -1,842 | -3,173 | -1,205 | -1,200 | |
From Financial Activity | Rs m | -1,975 | -2,719 | -583 | -16 | -41 | |
Net Cashflow | Rs m | 127 | 147 | 43 | -291 | -18 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rajender Mohan Malla | COMP SEC: Abhay Raj Singh | YEAR OF INC: 1986 | BSE CODE: 524164 | FV (Rs): 10 | DIV YIELD (%): 1.0 |
Read: IOL CHEMICALS & PHARM. 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets continued the momentum as the session progressed and ended the higher.